BioSig Appoints John W. Osborn, Ph.D. as Consultant on Autonomic Neuromodulation
March 04, 2020 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, March 04, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig to Webcast its Presentation at the Cowen and Company’s 40th Annual Health Care Conference
March 03, 2020 12:20 ET
|
BioSig Technologies, Inc.
Westport, CT, March 03, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig to Present at the Cowen & Co. 40th Annual Health Care
February 26, 2020 08:33 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 26, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Announces Closing of Public Offering of Common Stock
February 25, 2020 15:25 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 25, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Announces $10 Million Public Offering of Common Stock
February 21, 2020 08:45 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Announces Proposed Public Offering of Common Stock
February 20, 2020 16:18 ET
|
BioSig Technologies, Inc.
Westport, CT, Feb. 20, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal...
BioSig Completes 100th Patient Case with PURE EP(TM) System
February 19, 2020 08:33 ET
|
BioSig Technologies, Inc.
WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Commercialization and install plan ahead of scheduleInstallations at new centers are driving patient enrollments and clinical data collection BioSig...
BioSig to Present at the 25th Annual International AF Symposium
January 21, 2020 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
BioSig to Commence Patient Cases at Mayo Clinic
January 16, 2020 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 16, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
BioSig Awarded Additional US Patent Claims for its PURE EP(TM) System
January 14, 2020 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Company allowed a fifth utility patent Claims address methods for removing voltage offset from biomedical signalsEleven additional patent applications...